Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses ...
Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict ...
Building on recent successes, scientists are focused on a promising new frontier: sending tiny particles into the body to ...
Morning Overview on MSN
GLP-1 weight-loss drugs may slow cancer’s spread, a 10,000-patient study found
A study tracking more than 10,000 patients with early-stage, obesity-related cancers found that those taking GLP-1 receptor ...
On 1 June 2026, the European Commission published a communication setting out a roadmap to phase out animal testing for ...
The global stem cell banking market is experiencing robust compound annual growth rate (CAGR) expansion, driven by escalating demand-side dynamics, rising awareness of regenerative medicine ...
The field of cancer genomics is rapidly evolving, driven by advanced technologies that enable detailed characterization of cancer initiation, progression, ...
Exelixis, Inc.'s STELLAR-303 zanzalintinib data disappoints in colorectal cancer with an FDA decision due in December 2026.
A team at Roswell Park Comprehensive Cancer Center has identified a novel metabolic pathway that plays a key role in enabling ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
Scientists at USC have developed a way to create a renewable supply of immune cell precursors that can be grown in large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results